Elsevier makes all content on COVID-19 Information Center available to PubMed Central

From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health’s National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing. This additional access allows researchers to use artificial intelligence to keep up with the rapidly growing body of literature and identify trends as countries around the world address this global health crisis.

In January, Elsevier created the COVID-19 Information Center with free information in English and Mandarin on the novel coronavirus. The Information Center is updated daily with the latest research information on the virus and the disease and includes links to more than 19,500 freely available articles on ScienceDirect, Elsevier’s platform of peer-reviewed scholarly literature. Since its launch, the Information Center has been visited by more than a quarter of a million scientists, researchers, clinicians and others, 15 percent of whom are in the US.

The COVID-19 Information Center is hosted on Elsevier Connect, the company’s public news and information website. It is curated by Elsevier clinicians and other experts and brings together content from the company’s medical journals, textbooks and clinical information solutions as well as resources from other information providers and major health and government organizations. Also available is information typically used by practicing nurses and physicians, plus resources designed specifically for patients and their families.

To improve the discoverability and utility of this important body of knowledge, Elsevier has made available all its research and data on the COVID-19 Info Center, as well copies provided to PubMed Central and other publicly funded repositories, in a machine-readable format with rights for full text and data mining, re-use and analyses for as long as needed while the public health emergency is ongoing.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elsevier. (2020, March 17). Elsevier makes all content on COVID-19 Information Center available to PubMed Central. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20200317/Elsevier-makes-all-content-on-COVID-19-Information-Center-available-to-PubMed-Central.aspx.

  • MLA

    Elsevier. "Elsevier makes all content on COVID-19 Information Center available to PubMed Central". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20200317/Elsevier-makes-all-content-on-COVID-19-Information-Center-available-to-PubMed-Central.aspx>.

  • Chicago

    Elsevier. "Elsevier makes all content on COVID-19 Information Center available to PubMed Central". News-Medical. https://www.news-medical.net/news/20200317/Elsevier-makes-all-content-on-COVID-19-Information-Center-available-to-PubMed-Central.aspx. (accessed November 22, 2024).

  • Harvard

    Elsevier. 2020. Elsevier makes all content on COVID-19 Information Center available to PubMed Central. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20200317/Elsevier-makes-all-content-on-COVID-19-Information-Center-available-to-PubMed-Central.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.